NFE2L2 and systemic lupus erythematosus: Combined, these studies demonstrated downregulation of the Nrf2 pathway in kidneys, MDSCs from spleen, and macrophages during pristane-induced SLE and highlighted the role of Nrf2 inhibition of interferon signaling.